Covid-19 and its impact on the world has redefined the idea of the word ‘luxury’ for Morningside Pharmaceuticals’ Chairman Dr Nik Kotecha OBE.
“I recently read a great piece of writing entitled ‘what is luxury’, which got me thinking.
It says that luxury was the rare, the expensive, everything that seemed unattainable. But we now realise that luxuries were those little things that we did not know how to value when we had them. And now that they are gone, we miss them most.
Luxury is now about being healthy, being able to walk around your local area whenever you like, breathing without wearing a mask and meeting with family and friends.
Life is precious and we should appreciate more the simple luxuries that we have.
With this in mind, from the beginning of the pandemic the welfare of our employees, as well as ensuring patient safety have been our top priorities.
We adapted quickly and brought in more people wellbeing policies such as flexible working and opened up a new building, earlier than planned, to ensure social distancing in our offices. Changes to our quality management system (QMS) and working processes were essential for ensuring that disruption was kept to a minimum.
New technology such as video conferencing has also been embedded throughout the company, and we have taken the opportunity to improve, such as investing in enhanced cyber security and increased digitisation.
We are also mindful that remote working can cause other issues, such as having a negative impact on people’s mental health. So we have brought in extra support to help people who are facing difficulties as a consequence of the ongoing social restrictions.”